Digest Network Come funziona
Network
/
Società
Dy
Non verificato

Dyadic International, Inc.

Di cosa scriviamo

Annunci EconomiciBiotecnologiaManagement/Organizzazione AziendaleMedicina Salute Benessere

15 comunicati stampa

Guarda tutti i comunicati
04/08/2026
Biotecnologia
Medicina Salute Benessere
Annunci Economici
Dyadic Expands Commercial Non-Animal Dairy Pipeline Through New Strategic Development Agreement
Fonte
Dyadic International, Inc.
Emittente
GLOBENEWSWIRE
1.00
0
28/07/2026
Biotecnologia
Medicina Salute Benessere
Dyadic Develops Stable C1 Cell Lines and Produces Purified Scripps-Designed Bundibugyo Ebola Antigens from Plasmids in Approximately 15 Days
Fonte
Dyadic International, Inc.
Emittente
GLOBENEWSWIRE
1.00
0
16/07/2026
Biotecnologia
Annunci Economici
Dyadic Expands Bio industrial Pipeline with New Proprietary Industrial Enzyme Program
Fonte
Dyadic International, Inc.
Emittente
GLOBENEWSWIRE
1.00
0
07/07/2026
Biotecnologia
Medicina Salute Benessere
Global Collaborations Continue to Validate Dyadic’s C1 Platform and Expands Commercial Potential
Fonte
Dyadic International, Inc.
Emittente
GLOBENEWSWIRE
1.00
0
29/06/2026
Biotecnologia
Annunci Economici
Dyadic Expands IP Protection and Business Development Activities in Japan
Fonte
Dyadic International, Inc.
Emittente
GLOBENEWSWIRE
1.00
0
15/06/2026
Biotecnologia
Medicina Salute Benessere
Dyadic Highlights Accelerated Interest in C1 Biomanufacturing Platform Amid Ebola Preparedness Activities and Growing Commercial Adoption
Fonte
Dyadic International, Inc.
Emittente
GLOBENEWSWIRE
1.00
0
28/05/2026
Biotecnologia
Medicina Salute Benessere
Management/Organizzazione Aziendale
Dyadic and Scripps Research Collaborate on Rapid-Response Hantavirus Antibody and Vaccine Development
Fonte
Dyadic International, Inc.
Emittente
GLOBENEWSWIRE
1.00
0
16/03/2026
Biotecnologia
Management/Organizzazione Aziendale
Dyadic Applied BioSolutions Announces Commercial Distribution Partnership with IBT Bioservices
Fonte
Dyadic International, Inc.
Emittente
GLOBENEWSWIRE
1.00
0
04/03/2026
Biotecnologia
Management/Organizzazione Aziendale
Annunci Economici
Dyadic and Fermbox Bio Launch First Product Under Expanded Collaboration: Animal-Origin-Free Recombinant DNase I (RNase-Free)
Fonte
Dyadic International, Inc.
Emittente
GLOBENEWSWIRE
1.00
0
02/03/2026
Biotecnologia
Annunci Economici
Dyadic Applied BioSolutions and Inzymes ApS Announce Planned 2026 Commercialization of Non-Animal Dairy Enzyme Following Achievement of Development Milestone
Fonte
Dyadic International, Inc.
Emittente
GLOBENEWSWIRE
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0